Enterprise Therapeutics
UKEntry
2024
Hold
2yr
Status
Active
Who owns Enterprise Therapeutics?
Enterprise Therapeutics is currently owned by Panakes Partners SGR through Panakes Fund Purple (2021 vintage), since 2024.
Hand-verified · updated 2026-07-23
More from Panakes Fund Purple
Other portfolio companies in the same fund.
Spain
US
Italy
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Enterprise Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Enterprise Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Enterprise Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue